CONFERENCE COVERAGE SERIES
Fondation André-Delambre, 2009 Symposium on Amyotrophic Lateral Sclerosis
Québec City, Canada
25 – 26 September 2009
Researchers need to meet each year to advance the cause of research into ALS,” was the message of Monica Lalancette, neurologist and researcher at CHU Université Laval, and of Jean-Pierre Julien, a professor at Université Laval. The gathering of experts from around the world became a reality at the 5th Symposium on Amyotrophic Lateral Sclerosis. Some 100 invited guests attended a series of talks on the clinical promise of stem cells, organogenesis and genetics. “The symposium also included students,” Nicolas Dupré, neurologist at Hôpital de l’Enfant-Jésus and associate professor at Université Laval, points out. “It’s a way of encouraging them to consider a career in ALS research, rather than in another field.
Québec: Stem Cells in ALS Update
Stem cell research made a strong showing at the André-Delambre Foundation Symposium on amyotrophic lateral sclerosis (ALS)...
Québec: Transporters, Antibodies Offer Potential ALS Therapies
The doctor’s toolkit for amyotrophic lateral sclerosis is pathetically small—only one drug, riluzole, is approved for the disease, and its effects are hardly blockbuster...
Québec: STOMPing on Inclusions May Reveal their True Identity
The nervous systems of people with neurodegenerative disease are often pocked with tiny inclusions, which are packed with a variety of proteins, many still unidentified...
Québec: Chromogranins Help SOD1 Do Its Dirty Work
Mutant superoxide dismutase 1 (SOD1) has been linked to one-fifth of inherited cases of ALS, where its misfolded form appears to damage motor neurons...